ArticleBlood advances2017
Interleukin-6 levels predict event-free survival in pediatric AML and suggest a mechanism of chemotherapy resistance.
Alexandra M Stevens et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
51 papers cite it
this papertrialcites it